Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;10(4):37-46.

A Review of the Global Guidelines on Surgical Margins for Nonmelanoma Skin Cancers

Affiliations
Review

A Review of the Global Guidelines on Surgical Margins for Nonmelanoma Skin Cancers

Amanda F Nahhas et al. J Clin Aesthet Dermatol. 2017 Apr.

Abstract

Background: Adequate treatment and follow-up of a patient with nonmelanoma skin cancer is of utmost concern for a clinician. However, there is a lack of international consensus on recommendations for surgical excision margins. Furthermore, lack of familiarity of the published guidelines leads to a variety in practice styles. Objective: To compare the consistency in global recommendations for surgical excision margins for basal cell carcinoma, cutaneous squamous cell carcinoma, dermatofibrosarcoma protuberans, and Merkel cell carcinoma. Methods: A review of the current literature and global guidelines for surgical excision margins for basal cell carcinoma, cutaneous squamous cell carcinoma, dermatofibrosarcoma protuberans, and Merkel cell carcinoma. Results: Upon review of international guidelines, variations do exist among guidelines for peripheral and deep surgical margins. Guideline recommendations were found to be more globally consistent in margin selection for low-risk basal cell carcinoma and low-risk cutaneous squamous cell carcinoma, however, least consistent when concerning margin selection for dermatofibrosarcoma protuberans and Merkel cell carcinoma. Conclusion: Although guidelines exist, there is a need for international collaboration and consensus to determine a more unified and evidence-based approach to surgical excision as a treatment for nonmelanoma skin cancer.

PubMed Disclaimer

Conflict of interest statement

Disclosure:The authors have no conflicts of interest relevant to the content of this article.

References

    1. Guy G, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002–2006 and 2007–2011. Am J Prev Med. 2015;48(2):183–187. - PMC - PubMed
    1. Connolly SM, Baker DR, Coldiron BM, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012;67(4):531–550. - PubMed
    1. What are the key statistics about basal and squamous cell skin cancers? American Cancer Society. [Accessed on March 11, 2016]. http://www.cancer.org
    1. Habif T. Premalignant and malignant nonmelanoma skin tumors. In: Habif T, editor. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 5. Mosby Elsevier Inc; 2009. pp. 804–831.
    1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology; basal cell skin cancer. [Accessed on January 4, 2017]. http://www.nccn.org

LinkOut - more resources